Charles Schwab
GDRX icon

Charles Schwab’s GoodRx Holdings GDRX Stock Holding History

Charles Schwab’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Sell
553,844
-8,792
-2% -$22.3K ﹤0.01% 2862
2026
Q1 		$1.1M Buy
562,636
+87,027
+18% +$204K ﹤0.01% 2875
2025
Q4 		$1.29M Sell
475,609
-51,661
-10% -$170K ﹤0.01% 2845
2025
Q3 		$2.23M Buy
527,270
+10,108
+2% +$44.4K ﹤0.01% 2724
2025
Q2 		$2.58M Sell
517,162
-1,779
-0.3% -$7.73K ﹤0.01% 2594
2025
Q1 		$2.29M Sell
518,941
-19,647
-4% -$92.2K ﹤0.01% 2565
2024
Q4 		$2.5M Buy
538,588
+58,465
+12% +$321K ﹤0.01% 2609
2024
Q3 		$3.33M Buy
480,123
+26,262
+6% +$206K ﹤0.01% 2551
2024
Q2 		$3.54M Buy
453,861
+14,999
+3% +$111K ﹤0.01% 2510
2024
Q1 		$3.12M Buy
438,862
+565
+0.1% +$3.74K ﹤0.01% 2462
2023
Q4 		$2.94M Buy
438,297
+21,557
+5% +$121K ﹤0.01% 2508
2023
Q3 		$2.35M Buy
416,740
+26,832
+7% +$179K ﹤0.01% 2552
2023
Q2 		$2.15M Buy
389,908
+76,005
+24% +$409K ﹤0.01% 2525
2023
Q1 		$1.96M Sell
313,903
-67,091
-18% -$374K ﹤0.01% 2528
2022
Q4 		$1.78M Sell
380,994
-2,282
-0.6% -$11.2K ﹤0.01% 2604
2022
Q3 		$1.79M Buy
383,276
+40,516
+12% +$255K ﹤0.01% 2614
2022
Q2 		$2.03M Sell
342,760
-5,717
-2% -$63.6K ﹤0.01% 2564
2022
Q1 		$6.74M Buy
348,477
+35,130
+11% +$806K ﹤0.01% 2142
2021
Q4 		$10.2M Buy
313,347
+3,128
+1% +$126K ﹤0.01% 1985
2021
Q3 		$12.7M Buy
310,219
+10,231
+3% +$371K ﹤0.01% 1869
2021
Q2 		$10.8M Buy
299,988
+115,139
+62% +$4.25M ﹤0.01% 1954
2021
Q1 		$7.21M Buy
184,849
+6,189
+3% +$278K ﹤0.01% 2123
2020
Q4 		$7.21M Buy
+178,660
New +$8.21M ﹤0.01% 2045

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Charles Schwab's GDRX Position: Q2 2026 in Review

Charles Schwab reduced its GoodRx Holdings (GDRX) stake by 1.6% in Q2 2026, selling an estimated $22.3K and leaving 553,844 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2862.

Charles Schwab first reported a position in GDRX in Q4 2020 and has held it in 23 quarters since. The position peaked at $12.7M in Q3 2021. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Charles Schwab held 553,844 shares of GoodRx Holdings worth $1.6M as of Q2 2026.
  • Charles Schwab sold 8,792 GoodRx Holdings shares in Q2 2026, an estimated $22.3K.
  • GoodRx Holdings made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2862 holding.
  • Charles Schwab first reported a position in GoodRx Holdings in Q4 2020 and has held it in 23 quarters since.
  • Charles Schwab's GoodRx Holdings position peaked at $12.7M in Q3 2021.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.